Liu, Si-Yang Maggie
Zheng, Mei-Mei
Pan, Yi
Liu, Si-Yang
Li, Yangqiu
Wu, Yi-Long
Funding for this research was provided by:
National Natural Science Foundation of China (82202997, 82002413)
China Postdoctoral Science Foundation (2021M701422)
Key Lab System Project of Guangdong Science and Technology Department, Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2017B030314120)
Guangdong Provincial People's Hospital Scientific Research Funds for Leading Medical Talents in Guangdong Province (KJ012019426)
Article History
Received: 10 October 2022
Accepted: 30 March 2023
First Online: 17 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: Yi-Long Wu discloses the following personal financial interests: Consulting and advisory services, speaking engagements of Roche, AstraZeneca, Eli Lilly, Boehringer Ingelheim, Sanofi, MSD, and BMS. The other authors have no conflict of interest.